SCHEMBL21701412

SCHEMBL21701412

CCOc1ccccc1N1CCN(c2ccc(NC(=O)c3ccc(OC)cc3)c(C(=O)O)c2)CC1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
ALDH1A1 P00352 3/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
POLB P06746 1/20 0.53
MAPT P10636 3/20 0.52
GAA P10253 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
CYP2D6 P10635 1/20 0.52
NPC1 O15118 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
RAB9A P51151 1/20 0.51
ADRA1D P25100 3/20 0.51
ADRA1A P35348 3/20 0.51
ADRA1B P35368 3/20 0.51
F10 P00742 6/20 0.50
CYP3A4 P08684 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21701410 0.92 POLB (0.57) KMT2APOLBMAPTGAAADRA1D
SCHEMBL21701424 0.89 GAA (0.59) KMT2APOLBMAPTGAAADRA1D
SCHEMBL21701423 0.86 POLB (0.57) KMT2AMEN1ALDH1A1L3MBTL1POLB
SCHEMBL21701456 0.86 POLB (0.57) KMT2AMEN1L3MBTL1POLBMAPT
SCHEMBL21701415 0.86 POLB (0.67) KMT2AMEN1ALDH1A1L3MBTL1POLB
SCHEMBL21701425 0.85 POLB (0.55) KMT2AMEN1ALDH1A1L3MBTL1POLB
SCHEMBL21701427 0.83 MAPT (0.57) POLBMAPTNPC1RAB9AF10
SCHEMBL21701458 0.83 MAPT (0.54) KMT2AMEN1ALDH1A1POLBMAPT
SCHEMBL21701457 0.82 ALDH1A1 (0.66) ALDH1A1L3MBTL1POLBMAPTGAA
SCHEMBL21701605 0.81 MAPT (0.57) KMT2APOLBMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020033944-A2 NON-POLYAMINE BASED POLYAMINE TRANSPORT INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN CANCERS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2020-02-13 WO disclosed